ebook Munafa Stock Market Course + Intraday & FNO calls  

       

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Glenmark Pharmaceuticals Limited Complete list of announcements declared & dividend announcements by Glenmark Pharmaceuticals Limited GLENMARK

Glenmark Pharmaceuticals Limited GLENMARK listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Glenmark Pharmaceuticals Limited GLENMARK

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP,
Announcement as on 23 December 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 16, 2025, titled "Glenmark Secures Exclusive Multi-Regional Rights to Aumolertinib, an MHRA and NMPA approved Third-Generation EGFR-TKI, from Hansoh Pharma"
Announcement as on 16 December 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled "Glenmark Pharmaceuticals Inc., USA to launch Leucovorin Calcium for Injection USP, 350 mg/vial Single-Dose Vial".
Announcement as on 11 December 2025

Company Announcement
Update on the Company's Chhatrapati Sambhajinagar (Aurangabad) Facility
Announcement as on 01 December 2025

Company Announcement
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 27, 2025, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility".
Announcement as on 27 November 2025

Announcements by Glenmark Pharmaceuticals Limited first page | Next page |

GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals

Moving Averages for Glenmark Pharmaceuticals Limited

  • 5Day Average: 2033.08
  • 12Day Average: 2014.91
  • 20Day Average: 1992.07
  • 50Day Average: 1921.25
  • 100Day Average: 1953.93
  • 150Day Average: 1924.96
  • 200Day Average: 1801.13

GLENMARK Indicators & signals

Indicator MACD (12,26,9)

2017.27, 1985.03, 29.07
Indicator MACD is in positive zone

Indicator ADX (14)

30.53, 30.8, 16.39
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Fri Jan 2026 2064.50 2021.00 to 2073.00 1.89% 0.56 times
01 Thu Jan 2026 2026.20 2011.00 to 2039.10 -0.44% 0.4 times
31 Wed Dec 2025 2035.20 2025.70 to 2048.40 0.27% 0.52 times
30 Tue Dec 2025 2029.80 2000.00 to 2039.00 1% 3.3 times
29 Mon Dec 2025 2009.70 2000.40 to 2028.50 -0.04% 0.38 times
26 Fri Dec 2025 2010.60 2004.30 to 2025.90 -0.47% 0.3 times
24 Wed Dec 2025 2020.10 2013.80 to 2054.90 -1.31% 0.83 times
23 Tue Dec 2025 2047.00 2036.50 to 2082.50 0.43% 2.01 times
22 Mon Dec 2025 2038.20 1992.10 to 2042.70 2.31% 1.01 times
19 Fri Dec 2025 1992.10 1952.60 to 1996.20 1.79% 0.75 times
18 Thu Dec 2025 1957.10 1920.20 to 1959.40 0.45% 0.51 times
17 Wed Dec 2025 1948.40 1935.40 to 1976.70 -0.92% 0.41 times

Videos related to: GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

GLENMARK announcements Glenmark Pharmaceuticals Limited announcements and dividends declared NSE

 

Back to top